17.08.1979
6593826
katri.abel-ollo@tai.ee

Career

Institution(s) and position(s)
2002–...   
National Institute for Health Development, Researcher (1,00)
01.01.2001–31.12.2001   
Estonian Foundation for Prevention of Drug Addiction, project co-ordinator
 
 
Education
2004–2006   
University of Tartu, Faculty of Medicine, Department of Public Health (MScPH)

Publications

Category
Year
Publication
 
6.7.
2015
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2013
1.1.
2012
1.1.
2011
1.1.
2011
1.1.
2010
1.1.
2010
1.1.
2009
1.1.
2009
1.1.
2009
1.1.
2008
1.1.
2007
1.1.
2006
22.07.2019
17.08.1979
6593826
katri.abel-ollo@tai.ee

Teenistuskäik

Töökohad ja ametid
2002–...   
Tervise Arengu Instituut, Teadur (1,00)
01.01.2001–31.12.2001   
Eesti Uimastipreventsiooni Sihtasutus, projekti koordinaator.
 
 
Haridustee
2004–2006   
Tartu Ülikool, arstiteaduskond, rahvatervise teadusmagistriõpe (MScPH)

Publikatsioonid

Klass
Aasta
Publikatsioon
 
6.7.
2015
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2013
1.1.
2012
1.1.
2011
1.1.
2011
1.1.
2010
1.1.
2010
1.1.
2009
1.1.
2009
1.1.
2009
1.1.
2008
1.1.
2007
1.1.
2006
22.07.2019
  • Found 18 results
PublicationAuthorsYearSource titleClassificationFileInstitutions
Ohutu süstimise ruumide efektiivsusKiisk, Ele; Abel-Ollo, Katri; Pääsukene, Anna-Liisa; Lutsar, Katrin; Reile, Rainer; Kutsar, Andres; Kiivet, Raul-Allan20182.5.University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health
HIVi levimuse ja riskikäitumise uuring Narva süstivate narkomaanide seas (2014) Vorobjov S, Rüütel K, Salekešin M, Abel-Ollo K20156.7.National Institute for Health Development
HIVi levimuse ja riskikäitumise uuring Narva süstivate narkomaanide seas 2014. Uuringu kokkuvõteVorobjov, Sigrid; Rüütel, Kristi; Abel-Ollo, Katri; Salekešin, Maris20156.7.National Institute for Health Development
Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian populationHuik, K.; Avi, R.; Uibopuu, H.; Pauskar, M.; Margus, T.; Karki, T.; Krispin, T.; Kool, P.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Carrillo, AQ.; He, W.; Ahuja, SK.; Lutsar, I.2014Jaids-Journal of Acquired Immune Deficiency Syndromes1.1.University of Tartu, Faculty of Medicine, Department of Microbiology, Chair of Medical Microbiology and Virology;
University of Tartu, Faculty of Medicine, Department of Radiology;
University of Tartu, Faculty of Medicine, Department of Pediatrics, Chair of Paediatrics;
Estonian Biocentre
A decline in the prevalence of injecting drug users in Estonia, 2005–2009Uusküla, Anneli; Rajaleid, Kristiina; Talu, Ave; Abel-Ollo, Katri; Des Jarlais, Don2013International Journal of Drug Policy1.1.National Institute for Health Development;
University of Tartu, Faculty of Medicine, Department of Public Health
CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug UsersHuik, K; Avi, R; Carrillo, A; Harper, N; Pauskar, M; Sadam, M; Karki, T; Krispin, T; He, W; Lutsar, I2013PLOS ONE1.1.University of Tartu;
North Estonian Regional Hospital
Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveysVorobjov, S; Des Jarlais, DC; Abel-Ollo, K; Talu, A; Rüütel, K; Uusküla, A2013International Journal of Drug Policy1.1.National Institute for Health Development;
University of Tartu, Faculty of Medicine, Department of Public Health
Multiple routes of drug administration and HIV risk among injecting drug users.Vorobjov S, Uusküla A, Des Jarlais DC, Abel-Ollo K, Talu A, Rüütel K.2012The Journal of Substance Abuse Treatment1.1.National Institute for Health Development;
University of Tartu, Faculty of Medicine, Department of Public Health
Condom use and partnership intimacy among drug injectors and their sexual partners in EstoniaUusküla, A.; Abel-Ollo, K.; Markina, A.; McNutt, LA.; Heimer, R.2011Sexually Transmitted Infections1.1.University of Tartu, Faculty of Medicine, Department of Public Health;
University of Tartu, Faculty of Law, Institute of Public Law, Chair of Criminal Law
Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, EstoniaUusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I.2011BMC Public Health1.1.University of Tartu, Faculty of Medicine, Department of Public Health;
National Institute for Health Development;
University of Tartu, Estonian Genome Center
CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug usersHuik, K.; Sadam, M.; Karki, T.; Avi, R.; Krispin, T.; Paap, P.; Rüütel, K.; Uusküla, A.; Talu, A.; Abel-Ollo, K.; Lutsar, I.2010The Journal of Infectious Diseases1.1.University of Tartu, Faculty of Medicine, Department of Microbiology, Chair of Medical Microbiology and Virology;
University of Tartu, Faculty of Medicine, Department of Public Health;
University of Tartu, Faculty of Medicine, Department of Microbiology;
National Institute for Health Development
HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: Implications for interventionTalu, A.; Rajaleid, K.; Abel-Ollo, K.; Rüütel, K.; Rahu, M.; Rhodes, T.; Platt, L.; Bobrova, N.; Uusküla, A.2010International Journal of Drug Policy1.1.National Institute for Health Development;
University of Tartu, Faculty of Medicine, Department of Public Health, Chair of Epidemiology and Biostatistics
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, EstoniaVorobjov, S.; Uuskula, A.; Abel-Ollo, K.; Talu, A.; Ruutel, K.; Des Jarlais, D.C.2009Harm reduction journal1.1.National Institute for Health Development;
University of Tartu, Faculty of Medicine, Department of Public Health
Knowledge of HIV serostatus and risk behaviour among injecting drug users in EstoniaAbel-Ollo, K.; Rahu, M.; Rajaleid, K.; Talu, A.; Rüütel, K.; Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A.2009AIDS care1.1.National Institute for Health Development;
University of Tartu
Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, EstoniaVorobjov, S.; Uusküla, A.; Abel-Ollo, K.; Talu, A.; Des Jarlais, D.2009Journal of Urban Health1.1.University of Tartu, Faculty of Medicine, Department of Public Health;
National Institute for Health Development
High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programsUusküla, A.; Kals, M.; Rajaleid, K.; Abel, K.; Talu, A.; Rüütel, K.; Platt, L.; Rhodes, T.; Dehovitz, J.; Des Jarlais, D.2008Journal of Public Health1.1.National Institute for Health Development;
University of Tartu, Faculty of Medicine, Department of Public Health;
University of Tartu, Faculty of Medicine, Department of Public Health, Chair of Epidemiology and Biostatistics
Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004Uusküla, A.; Rajaleid, K.; Talu, A.; Abel, K.; Rüütel, K.; Hay, G.2007Addiction Research and Theory1.1.University of Tartu, Faculty of Medicine, Department of Public Health;
Tartu University Hospital, Dermatology Clinic of Tartu University Hospital
High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environmentPlatt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A.; Parry, JV.; Rüütel, K.; Talu, A.; Abel, K.; Rajaleid, K.; Judd, A.2006AIDS1.1.University of Tartu, Faculty of Medicine, Department of Public Health, Chair of Epidemiology and Biostatistics;
Tartu University Hospital, Dermatology Clinic of Tartu University Hospital;
National Institute for Health Development